Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

The management of chronic thromboembolic pulmonary hypertension has significantly changed over the last decade with the availability of both specific therapies and interventional treatments. In parallel, implantable pumps for intravenous administration of treprostinil have broadened the spectrum of...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Regina Steringer-Mascherbauer, Charlotte Huber, Uwe Fröschl, Dagmar Engleder, Reinhold Függer, Maria Lummersdorfer, Ralf Lenhard, Martin Martinek
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	MDPI AG 2023-07-01
Σειρά:	Journal of Cardiovascular Development and Disease
Θέματα:	chronic thromboembolic pulmonary hypertension implantable pump intravenous treprostinil
Διαθέσιμο Online:	https://www.mdpi.com/2308-3425/10/8/318

Παρόμοια τεκμήρια

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
ανά: Pavel Jansa, κ.ά.
Έκδοση: (2023-07-01)

Long-term experience with implantable infusion pumps for intravenous treprostinil in pulmonary arterial hypertension—procedural safety and system-related complications
ανά: Regina Steringer-Mascherbauer, κ.ά.
Έκδοση: (2020-11-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
ανά: John W. Swisher, PhD, MD, κ.ά.
Έκδοση: (2017-01-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
ανά: Jan C. Kamp, κ.ά.
Έκδοση: (2021-05-01)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
ανά: Marcin Kurzyna, κ.ά.
Έκδοση: (2017-12-01)

Venoarterial extracorporeal membrane oxygenation for vasoplegic shock after treprostinil refill of an implanted intravenous pump: a case report
ανά: Lucía Valencia, κ.ά.
Έκδοση: (2024-01-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
ανά: Xiaofeng Wang, κ.ά.
Έκδοση: (2024-10-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
ανά: Julia McSweeney, κ.ά.
Έκδοση: (2023-04-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
ανά: Lianghua Xiao, κ.ά.
Έκδοση: (2024-09-01)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
ανά: Ibrahim Alissa, κ.ά.
Έκδοση: (2023-04-01)

Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia
ανά: Felix Rafael De Bie, κ.ά.
Έκδοση: (2022-07-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
ανά: Piotr Kędzierski, κ.ά.
Έκδοση: (2025-01-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
ανά: Enhuan Wei, κ.ά.
Έκδοση: (2023-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
ανά: Daniel Lachant, DO, κ.ά.
Έκδοση: (2025-05-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
ανά: Nicholas S. Hill, κ.ά.
Έκδοση: (2022-07-01)

Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
ανά: Aleksandra Judina, κ.ά.
Έκδοση: (2023-12-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
ανά: Aparna C. Swaminathan, κ.ά.
Έκδοση: (2024-11-01)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
ανά: Leslie A. Spikes, κ.ά.
Έκδοση: (2022-04-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
ανά: Helena Gauani, κ.ά.
Έκδοση: (2022-04-01)

Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report
ανά: Jacqueline Brewer, κ.ά.
Έκδοση: (2023-06-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
ανά: Shelsey W. Johnson, κ.ά.
Έκδοση: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
ανά: Garance Kopp, κ.ά.
Έκδοση: (2020-10-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
ανά: Helena Gauani, κ.ά.
Έκδοση: (2023-03-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
ανά: Donna Steinbacher, κ.ά.
Έκδοση: (2024-04-01)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
ανά: Eun Woo Choi, κ.ά.
Έκδοση: (2021-10-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
ανά: N. V. Marukyan, κ.ά.
Έκδοση: (2021-05-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
ανά: N M Danilov, κ.ά.
Έκδοση: (2019-04-01)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
ανά: Burger CD, κ.ά.
Έκδοση: (2024-05-01)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
ανά: Kelly Merrill, κ.ά.
Έκδοση: (2024-04-01)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
ανά: Cheng Hong, κ.ά.
Έκδοση: (2022-05-01)

Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
ανά: Zheng-Wei Chen, κ.ά.
Έκδοση: (2021-03-01)

Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation
ανά: Gil Bu Kang, κ.ά.
Έκδοση: (2023-11-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
ανά: Diederik P. Staal, κ.ά.
Έκδοση: (2024-07-01)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
ανά: Chen TX, κ.ά.
Έκδοση: (2018-01-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
ανά: Qi Jin, κ.ά.
Έκδοση: (2019-11-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
ανά: HUANG Shenshen, κ.ά.
Έκδοση: (2023-01-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
ανά: Amresh Raina, κ.ά.
Έκδοση: (2024-10-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
ανά: Jenna M. Faircloth, κ.ά.
Έκδοση: (2023-08-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
ανά: Jenna M. Faircloth, κ.ά.
Έκδοση: (2023-03-01)

Perioperative thromboembolism prophylaxis in children – is it necessary?
ανά: Izabela Pągowska-Klimek
Έκδοση: (2020-08-01)